madamswer, fruitbat & co have always been critical of MSB's management.
In fact he and several others have maintained that the CEO was out of his depth and had no commercial nous.
All nonsense.
Clearly the fact of the science being proven unequivocally has led to this stronger position.
Along with some others in here, I have always said it comes down to the science, and the risk was largely baked out of the science.
This was derided.
Ditto that the dosage levels would be changed, and delivery of the stem cells would be more targetted to achieve optimal results.
Ditto that the FDA would fast track stem cell technology.
This was derided by your so called experts, madamswer & co.
Along with other LT holders, I also said that MSB management have never shown any inclination to sell out cheaply.
This was loudly derided.
All that has happened are the perfectly predictable and logical extensions of what people like me have been saying.
within 6 mths time eyes on the prize guys, I thk the market will focus on the prize and the details later wont matter. A CR IMHO would have put a brake on the SP like in the past- this is brilliant.
I couldn't agree more, except it's totally in line with what many of we LT holders have been saying. You just caught on? OK.
Add to My Watchlist
What is My Watchlist?
